Fcf Advisors LLC Bristol Myers Squibb CO Transaction History
Fcf Advisors LLC
- $695 Million
- Q2 2025
A detailed history of Fcf Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fcf Advisors LLC holds 365,410 shares of BMY stock, worth $17.4 Million. This represents 2.44% of its overall portfolio holdings.
Number of Shares
365,410
Previous 291,499
25.36%
Holding current value
$17.4 Million
Previous $17.8 Million
4.86%
% of portfolio
2.44%
Previous 2.87%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,795Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.12 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.56 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.15 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.52 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.17 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $101B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...